| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities | -49,052 | -44,705 |
| Effect of exchange rate changes on cash | 219 | 260 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 64,656 | 36,080 |
| Cash and cash equivalents at beginning of period | 151,844 | - |
| Cash and cash equivalents at end of period | 216,500 | - |
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH)